UFP Technologies, Inc. (UFPT)
286.65
-5.79
(-1.98%)
USD |
NASDAQ |
Sep 03, 16:00
286.77
+0.12
(+0.04%)
After-Hours: 20:00
UFP Technologies Research and Development Expense (Annual) : 8.60M for Dec. 31, 2025
Research and Development Expense (Annual) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Research and Development Expense (Annual) Data
| Date | Value |
|---|---|
| December 31, 2025 | 8.60M |
| December 31, 2024 | 10.40M |
| December 31, 2023 | 7.20M |
| December 31, 2022 | 9.30M |
| December 31, 2021 | 8.50M |
| December 31, 2020 | 8.20M |
| December 31, 2019 | 9.50M |
| December 31, 2018 | |
| December 31, 2017 | 1.10M |
| December 31, 2016 | 1.30M |
| December 31, 2015 | 1.30M |
| December 31, 2014 | 1.20M |
| December 31, 2013 | 1.20M |
| December 31, 2012 | 0.00 |
| December 31, 2011 | 0.90M |
| December 31, 2010 |
| Date | Value |
|---|---|
| December 31, 2009 | |
| December 31, 2008 | |
| December 31, 2007 | |
| December 31, 2006 | |
| December 31, 2005 | |
| December 31, 2004 | |
| December 31, 2003 | |
| December 31, 2002 | |
| December 31, 2001 | |
| December 31, 2000 | |
| December 31, 1999 | |
| December 31, 1998 | |
| December 31, 1997 | 0.00 |
| December 31, 1996 | 0.00 |
| December 31, 1995 | 0.00 |
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Annual) Benchmarks
| Abbott Laboratories | 2.889B |
| AngioDynamics, Inc. | 29.45M |
| Alphatec Holdings, Inc. | 76.27M |
| AtriCure, Inc. | 90.17M |
| Baxter International, Inc. | 503.00M |